SCHEMBL20157564

SCHEMBL20157564

CC(Br)c1ccc(C(=O)c2ccc(F)cc2)c(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
ALDH1A1 P00352 4/20 0.42
ALPG P10696 2/20 0.42
TDP1 Q9NUW8 1/20 0.40
HPGD P15428 2/20 0.38
HTT P42858 2/20 0.38
USP2 O75604 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
LTA4H P09960 1/20 0.37
NPC1 O15118 1/20 0.36
KMT2A Q03164 2/20 0.36
RXRA P19793 1/20 0.36
MEN1 O00255 1/20 0.36
MAPK14 Q16539 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157556 0.88 LMNA (0.44) LMNASMN1; SMN2ALDH1A1ALPGTDP1
SCHEMBL21362519 0.85 KMT2A (0.44) SMN1; SMN2HPGDKMT2AMEN1
SCHEMBL20158052 0.85 LMNA (0.39) LMNASMN1; SMN2ALDH1A1ALPGTDP1
SCHEMBL21564971 0.81 CES2 (0.34) SMN1; SMN2ALDH1A1HPGDHTTKMT2A
SCHEMBL11860220 0.81 LTA4H (0.46) LMNASMN1; SMN2ALDH1A1ALPGHPGD
SCHEMBL20157488 0.80 HTT (0.49) LMNASMN1; SMN2ALDH1A1TDP1HPGD
SCHEMBL20157547 0.78 MAPT (0.50) LMNASMN1; SMN2ALDH1A1TDP1HTT
SCHEMBL21351930 0.78 LMNA (0.39) LMNASMN1; SMN2ALDH1A1ALPGTDP1
SCHEMBL21362658 0.77 AAK1 (0.35) LMNASMN1; SMN2ALDH1A1ALPGTDP1
SCHEMBL21362792 0.76 ALDH1A1 (0.44) ALDH1A1HPGDHTTNPSR1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed
WO-2018086605-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF 山东罗欣药业集团股份有限公司 2018-05-17 WO disclosed